Jump to content


Do you want up to date information about Scleroderma? Check out our Medical pages at www.sclero.org for all your Scleroderma questions!


Photo

The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis (SSc).

limited scleroderma diffuse scleroderma autoantibodies

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,505 posts
  • Location:West Sussex

Posted 02 July 2013 - 10:24 PM

The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis (SSc).

 

These data suggest that the current classification subdividing SSc into limited and diffuse cutaneous subtypes misclassifies an intermediate group of patients exhibiting unique autoantibody profile, disease course and clinical outcomes. Pub Med. Ann Rheum Dis. 2013 Apr 20. (Also see: Classification of Systemic Sclerosis)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)






Also tagged with one or more of these keywords: limited scleroderma, diffuse scleroderma, autoantibodies